PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Inogen, Inc. (INGN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS45780L1044
CUSIP45780L104
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$159.65M
EPS-$4.42
PEG Ratio3.48
Revenue (TTM)$315.66M
Gross Profit (TTM)$153.53M
EBITDA (TTM)-$45.68M
Year Range$4.13 - $14.10
Target Price$6.50
Short %7.75%
Short Ratio5.78

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Inogen, Inc.

Popular comparisons: INGN vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Inogen, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%150.00%200.00%NovemberDecember2024FebruaryMarchApril
-55.25%
177.38%
INGN (Inogen, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Inogen, Inc. had a return of 23.50% year-to-date (YTD) and -48.20% in the last 12 months. Over the past 10 years, Inogen, Inc. had an annualized return of -7.03%, while the S&P 500 had an annualized return of 10.52%, indicating that Inogen, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date23.50%6.92%
1 month-14.88%-2.83%
6 months61.05%23.86%
1 year-48.20%23.33%
5 years (annualized)-39.89%11.66%
10 years (annualized)-7.03%10.52%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202429.60%-6.54%21.35%
2023-15.94%-14.37%30.20%-5.67%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of INGN is 22, indicating that it is in the bottom 22% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of INGN is 2222
Inogen, Inc.(INGN)
The Sharpe Ratio Rank of INGN is 1919Sharpe Ratio Rank
The Sortino Ratio Rank of INGN is 2121Sortino Ratio Rank
The Omega Ratio Rank of INGN is 2222Omega Ratio Rank
The Calmar Ratio Rank of INGN is 2020Calmar Ratio Rank
The Martin Ratio Rank of INGN is 2626Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Inogen, Inc. (INGN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


INGN
Sharpe ratio
The chart of Sharpe ratio for INGN, currently valued at -0.61, compared to the broader market-2.00-1.000.001.002.003.004.00-0.61
Sortino ratio
The chart of Sortino ratio for INGN, currently valued at -0.58, compared to the broader market-4.00-2.000.002.004.006.00-0.58
Omega ratio
The chart of Omega ratio for INGN, currently valued at 0.92, compared to the broader market0.501.001.500.92
Calmar ratio
The chart of Calmar ratio for INGN, currently valued at -0.49, compared to the broader market0.002.004.006.00-0.49
Martin ratio
The chart of Martin ratio for INGN, currently valued at -0.97, compared to the broader market0.0010.0020.0030.00-0.97
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.19, compared to the broader market-2.00-1.000.001.002.003.004.002.19
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.18, compared to the broader market-4.00-2.000.002.004.006.003.18
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.501.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.68, compared to the broader market0.002.004.006.001.68
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.62, compared to the broader market0.0010.0020.0030.008.62

Sharpe Ratio

The current Inogen, Inc. Sharpe ratio is -0.61. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.61
2.19
INGN (Inogen, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Inogen, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-97.60%
-2.94%
INGN (Inogen, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Inogen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Inogen, Inc. was 98.51%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current Inogen, Inc. drawdown is 97.60%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.51%Sep 17, 20181288Oct 27, 2023
-46.25%Sep 17, 2015102Feb 11, 2016124Aug 9, 2016226
-32%Mar 13, 201440May 8, 201433Jun 25, 201473
-22.77%Jul 2, 201429Aug 12, 201419Sep 9, 201448
-18.1%Sep 10, 201429Oct 20, 201410Nov 3, 201439

Volatility

Volatility Chart

The current Inogen, Inc. volatility is 25.87%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%NovemberDecember2024FebruaryMarchApril
25.87%
3.65%
INGN (Inogen, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Inogen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items